Lumosa Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Employee Share Scheme | 1,890,000 | 1.15% |
Individual Insiders | 2,420,094 | 1.47% |
Institutions | 5,782,656 | 3.51% |
Private Companies | 14,878,248 | 9.02% |
Public Companies | 56,309,800 | 34.1% |
General Public | 83,693,027 | 50.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
55,149,800 | NT$10.2b | 99.4% | no data | |||
6,890,000 | NT$1.3b | 0% | no data | |||
6,761,123 | NT$1.3b | 25.4% | no data | |||
3,647,656 | NT$674.8m | 0% | 11.77% | |||
2,060,000 | NT$381.1m | 0% | 100.0% | |||
1,890,000 | NT$349.7m | 0% | no data | |||
1,226,125 | NT$226.8m | 0% | no data | |||
1,160,000 | NT$214.6m | -72.4% | no data | |||
979,942 | NT$181.3m | 0% | no data | |||
477,459 | NT$88.3m | 0% | no data | |||
476,057 | NT$88.1m | 0% | no data | |||
465,478 | NT$86.1m | 0% | no data | |||
75,000 | NT$13.9m | -23.5% | no data | |||
21,158 | NT$3.9m | 0% | no data | |||
1,000 | NT$186.2k | 0% | no data |